Table 1 Patient characteristics.
Study cohort (n = 80) | |
|---|---|
Male sex [n] | 61 (76) |
Age [years] | 57 (50–64) |
Aetiology of cirrhosis | |
Alcoholic [n] | 63 (79) |
Viral [n] | 5 (4) |
NASH [n] | 1 (1) |
Others [n] | 11 (14) |
Active alcohol consumption yes/no/unknown | 40/35/5 |
Alcoholic hepatitis [n] | 9 (11.3) |
Child-Pugh-Stage: A/B/C | 0/29/51 |
Child-Pugh-Score | 10 (9–12) |
MELD | 17 (11–23) |
SOFA-CLIF | 7 (4–9) |
ACLF: 0/I°/II°/III° | 56/14/5/5 |
Infections [n] | |
SBP [n] | 12 (15) |
Infection other than SBP [n] | 32 (40) |
Upper gastrointestinal bleeding [n] (%) | 10 (12.5) |
Mean arterial pressure [mmHg] | 87 (74–100) |
Diabetes mellitus [n] | 10 (12.5) |
Insulin therapy [n] | 6 (7.5) |
Leukocyte count [/nl] | 7.1 (5.0–11.7) |
Thrombocyte count [/nl] | 142 (96–189) |
C-reactive protein [mg/l] | 29.9 (13.3–60.9) |
Creatinine [µmol/l] | 85.5 (63.3–148.0) |
Bilirubin [mg/dl] | 2.08 (0.99–5.15) |
Albumin [g/l] | 24 (20–31) |
INR [AU] | 1.5 (1.2–1.9) |
ALT [µmol/(l × s)] | 0.56 (0.37–1.05) |
